RNA
- Avidity Biosciences, Inc.
()
Overview
Company Summary
Avidity Biosciences, Inc. is a biotechnology company that specializes in developing RNA-based therapies. Specifically, they are focused on leveraging the power of oligonucleotides to drive precise target binding and tissue-specific delivery.
The company's core technology, called AOC (Aurora� Oligonucleotide Conjugate), combines oligonucleotides with a peptide-based carrier system to increase selectivity and enhance the efficacy of RNA therapeutics. Through this innovative approach, Avidity aims to overcome the limitations of traditional oligonucleotide-based therapies, such as off-target effects and poor tissue penetration.
Avidity's technology platform has broad potential applications across various therapeutic areas, including rare genetic disorders, immunology, oncology, and muscle diseases. By modulating gene expression at the RNA level, the company's therapies have the potential to treat a wide range of diseases where traditional small molecules or biologics have been less effective.
In summary, Avidity Biosciences, Inc. focuses on developing RNA-based therapies using their proprietary AOC technology, aiming to provide more precise and effective treatments for various diseases.